两种骨转换标志物(CTX与P1NP)自动化检测方法的比较及丹麦人群参考区间
研究纳入Health2006研究中2308名24-76岁丹麦人,用IDS-iSYS与Roche Cobas e411两种自动化分析仪检测空腹血清CTX与P1NP并建立参考区间。两种P1NP检测法均差-3 μg/L(LoA -19至14,p<0.001),两种CTX检测法均差13 ng/L(LoA -187至214,p<0.001),存在显著不一致。作者据此按性别和年龄提出分层的参考区间,并强调检测方法标准化的必要性。
要点
- 两种P1NP检测法均差-3 μg/L(LoA -19至14,p<0.001),两种CTX检测法均差13 ng/L(LoA -187至214,p<0.001),均存在显著不一致。
- CTX存在系统性偏倚:低值时Cobas高于iSYS,高浓度时iSYS测值逐渐高于Cobas。
- 作者按性别和年龄提出参考区间(男性25-29、30-39、40-80岁;女性25-29、>30岁绝经前、>30岁绝经后),并主张随访复测应在同一检测方法上完成。
核心结论
- IDS-iSYS与Roche Cobas两种检测方法对CTX和P1NP均存在显著不一致,因此健康成人参考区间随所用分析方法不同而不同。
- 作者认为用于监测治疗的重复测量应在同一检测方法上完成,并应使用各方法特异的参考区间。
- 作者认为骨转换标志物检测方法的标准化十分必要。
研究设计与样本
- 研究分析了参加Health2006研究的2308人(1250名男性、1058名女性,年龄范围24-76岁)的空腹血清CTX和P1NP。
- 检测使用自动化IDS-iSYS分析仪和自动化Cobas e411分析仪。
- 正在接受抗骨质疏松治疗者被排除,使用激素避孕药者被纳入。
主要发现
- 两种P1NP检测法之间存在显著不一致,均差-3 μg/L(LoA -19至14)(p<0.001)。
- 两种CTX检测法之间存在显著不一致,均差13 ng/L(LoA -187至214)(p<0.001)。
- CTX存在系统性偏倚:低值时Cobas测值高于iSYS,较高浓度时iSYS测值逐渐高于Cobas。
关键数值与推荐
- 作者基于结果提出按性别分层的三个参考区间:男性为25-29岁、30-39岁、40-80岁;女性为25-29岁、>30岁(绝经前)、>30岁(绝经后)。
- P1NP两种检测法均差-3 μg/L(LoA -19至14)(p<0.001)。
- CTX两种检测法均差13 ng/L(LoA -187至214)(p<0.001)。
临床怎么用
- 作者认为用于监测治疗的重复测量应在同一检测方法上完成。
- 作者认为应使用各检测方法特异的参考区间。
- 作者认为骨转换标志物检测方法的标准化十分必要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Bone turnover markers are used for monitoring osteoporosis treatment. Therefore, we evaluated the agreement between different assays for CTX and PINP and established reference intervals in a cohort of 2300 individuals. We found poor agreement between assays and different reference intervals. This highlights the importance of harmonization of the assays. INTRODUCTION: Two reference markers for bone turnover have been proposed: CTX bone resorption and P1NP for bone formation. The purpose of the current study was to establish reference intervals for the two markers in a Danish cohort and to determine the agreement on the two platforms. METHODS: Fasting sera from 2308 individuals (1250 males and 1058 females, age range 24-76 years) participating in the Health2006 study were analyzed for CTX and P1NP using the automated IDS-iSYS analyzer and the automated Cobas e411 analyzer. Participants in anti-osteoporotic treatment were excluded, while subjects on hormonal contraceptives were included. RESULTS: There was significant disagreement between both the two P1NP assays with a mean difference of -3 μg/L (LoA -19 to 14) (p < 0.001) and the two CTX assays with a mean difference of 13 ng/L (LoA-187 to 214) (p < 0.001). For CTX, there was a systematic bias: at low values, Cobas measured a higher value than iSYS and at higher concentrations, iSYS measured increasingly higher values than Cobas. Based on the results, we propose three reference intervals for each sex: 25-29, 30-39, and 40-80 years for men, and 25-29, >30 (pre-menopausal), and >30 years (post-menopausal) for women. CONCLUSIONS: There is significant disagreement between the IDS-iSYS and Roche Cobas assays for both reference markers. Consequently, the reference intervals for an adult, healthy population are different depending on the analysis method used. Therefore, repeated measurements of patient samples used for monitoring of treatment should be done on the same assay. Moreover, assay-specific reference intervals should be used. Harmonization of assays for BTM is highly warranted.
引用
- Jørgensen NR, Møllehave LT, Hansen YBL, et al. Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population. Osteoporos Int. 2017. PMID: 28455749. doi:10.1007/s00198-017-4026-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。